Stock since the trade −0.6% · S&P 500 +1.2% · to Oct 5
The boss of Chemed sold $1.03M of Chemed shares. Nobody planned it ahead of time.
Loading…
CHE · NYSE · Health Care Services
Health Care Services company based in Cincinnati, Ohio.
In the last 90 days, no insider of Chemed Corp. reported an open-market purchase and 6 open-market sales worth about $4.83M. Every figure links to its official SEC, House, Senate or USAspending record.
Last closeLast close, Oct 5, 2026
$511.30
Last 12 months
Not enough history
Market value
$6.68B
Revenue
$673M
+8.8% vs the same quarter a year earlier
Free cash flow, last 12 months
$323M
This quarter $69.3M, a year earlier $123M
Net debt
$99.8M
Debt $140M, cash $40.2M, at Jun 30, 2026
Net income, last 12 months
$275M
Operating profit covers interest 106.5x
From the company's own quarterly and annual reports to the SEC. Free cash flow (cash from operations minus capital spending), net debt (debt minus cash) and 12-month totals are calculated by OQRO. Production rates, deliveries, approvals and guidance are in its results announcement of Jul 28, 2026.
Insiders buying, last 90 days
None
No open-market purchases reported
Insiders selling, last 90 days
6 sales
$4.83M sold. Insiders sell for many reasons.
New federal contracts, 12 months
None
Nothing found for this company
Revenue, fiscal 2025
$2.53B
+4.1% vs the year before
Net income, fiscal 2025
$265M
As reported in the annual filing
Shares outstanding
13.1M
As of Jun 30, 2026
In fiscal 2025 the company spent $432M buying back its own shares and $31.7M on dividends. Cash actually paid, from its cash-flow statement.
Stock since the trade −0.6% · S&P 500 +1.2% · to Oct 5
The boss of Chemed sold $1.03M of Chemed shares. Nobody planned it ahead of time.
Stock since the trade +1.4% · S&P 500 +1.7% · to Oct 5
The boss of Chemed sold $1M of Chemed shares. Nobody planned it ahead of time.
Stock since the trade −5.4% · S&P 500 +1.2% · to Oct 5
The boss of Chemed sold $1.08M of Chemed shares. Nobody planned it ahead of time.
Stock since the trade −5.4% · S&P 500 +1.2% · to Oct 5
Chemed's executive vice president sold $541K of Chemed shares. Nobody planned it ahead of time.
Stock since the trade −5.4% · S&P 500 +2.3% · to Oct 5
The boss of Chemed sold $1.08M of Chemed shares. Nobody planned it ahead of time.
Prices are daily closes from Polygon.io. Company figures come from its own SEC filings. Past moves are not a forecast. OQRO reports what was filed and never tells you what to buy or sell.
Last 12 months, adjusted daily closes
Adjusted close went from $435.38 on Oct 6, 2025 to $511.30 on Oct 5, 2026 (+17.4%). Disclosed activity in the last 12 months: 0 insider purchases, 13 insider sales, 0 Congress purchases, 0 Congress sales.